2 Einträge gefunden

1. Continuous Dosing Versus Interrupted Therapy with Ixekizumab: An Integrated Analysis of Two Phase 3 Trials in Psoriasis

   1. Blauvelt, Andrew
   2. Papp, K A
   3. Sofen, H L
   4. Augustin, M
   5. Yosipovitch, Gil
   6. Katoh, N
   7. Mrowietz, U

   2017 - Forschungsinformationssystem des UKE
2. Rapid Improvements in Health-related Quality of Life and Itch with Ixekizumab Treatment in Randomized Phase 3 Trials: Results from UNCOVER-2 and UNCOVER-3

   1. Leonardi, Craig L
   2. Blauvelt, Andrew
   3. Sofen, H L
   4. Gooderham, M
   5. Augustin, M
   6. Burge, R
   7. Zhu, B

   2017 - Forschungsinformationssystem des UKE